[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Christopher J. Williams, a director of Clorox Co. (CLX), reported two grants of Deferred Stock Units (DSUs) on a Form 4. On 08/29/2025 he received 199.8083 DSUs through dividend reinvestment; on 09/30/2025 he received 212.8954 DSUs in lieu of quarterly director fees. The DSUs are 1-for-1 and will be settled in Clorox common stock upon the reporting person’s retirement or other termination of director service. Following these transactions, the reporting person beneficially owns 19,458.9483 shares (reported as 19,246.0529 before the 09/30/2025 grant).

Positive

• Increased insider alignment via receipt of 412.7037 DSUs in 2025 (199.8083 + 212.8954)
• Settlement 1-for-1 into Clorox common stock strengthens long-term equity alignment

Negative

• None.

Insights

Corporate Governance Expert

Insider received non-cash director compensation as Deferred Stock Units that convert 1-for-1 into common stock.

The Form 4 shows the director acquired 199.8083 DSUs on 08/29/2025 via dividend reinvestment and 212.8954 DSUs on 09/30/2025 in lieu of fees, increasing beneficial ownership to 19,458.9483 shares.

This is a routine compensation-driven ownership change rather than an open-market purchase or sale, and the DSUs are structured to be settled 100% in Clorox stock upon the director’s retirement or termination of service.

Monitorable item: the DSUs will be settled in Clorox stock upon the reporting person’s retirement or other termination of director service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

WILLIAMS CHRISTOPHER J

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	08/29/2025		A(2)	V	199.8083		(3)	(3)	Common Stock	199.8083	$0.0000	19,246.0529	D
Deferred Stock Units	(1)	09/30/2025		A(4)		212.8954		(3)	(3)	Common Stock	212.8954	$0.0000	19,458.9483	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the CLX Form 4 filed by Christopher J. Williams report?

The Form 4 reported acquisition of 199.8083 DSUs on 08/29/2025 and 212.8954 DSUs on 09/30/2025, increasing beneficial ownership to 19,458.9483 shares.

How will the Deferred Stock Units held by the CLX director be settled?

The DSUs are to be settled 100% in Clorox common stock on the reporting person’s retirement or other termination of director service.

Why were the DSUs acquired on 08/29/2025 and 09/30/2025?

The 08/29/2025 DSUs were from dividend reinvestment; the 09/30/2025 DSUs were received in lieu of quarterly director fees.

What is the reporting person’s relationship to CLX?

The filer, Christopher J. Williams, is reported as a Director of Clorox Co. (CLX).

When was the Form 4 signed on behalf of the reporting person?

The Form 4 was signed by an attorney-in-fact, Jinho Joo, on 10/02/2025.